This NPR Short Wave podcast episode explores how psychedelics and ketamine affect the human brain, particularly focusing on their potential to enhance neuronal connections. While some patients can't take these substances due to prior mental health conditions or an aversion to the hallucinatory experience, research is ongoing into non-hallucinogenic alternatives. Companies like Delix Therapeutics are developing drugs inspired by psychedelics but without the associated trip. The debate continues in the field regarding the importance of the experiential component in therapy versus the potential of non-hallucinogenic options to expand treatment possibilities for diverse patient groups.
"Researchers are investigating how psychedelics and ketamine may enhance neuronal connections without necessarily invoking hallucinogenic experiences, aiming for treatments that are accessible to more patients."
"Some experts argue that the hallucinatory experiences induced by psychedelics are critical to their therapeutic effects, which complicates the pursuit of non-hallucinogenic alternatives."
Collection
[
|
...
]